Vitiligo
Symptoms, Doctors, Treatments, Advances & More

Learn About Vitiligo

What is the definition of Vitiligo?

Vitiligo is a skin condition in which there is a loss of color (pigment) from areas of skin. This results in uneven white patches that have no pigment, but the skin feels normal.

What are the alternative names for Vitiligo?

Autoimmune disorder - vitiligo

What are the causes of Vitiligo?

Vitiligo occurs when immune cells destroy the cells that make brown pigment (melanocytes). This destruction is thought to be due to an autoimmune problem. An autoimmune disorder occurs when the body's immune system, which normally protects the body from infection, attacks and destroys healthy body tissue instead. The exact cause of vitiligo is unknown.

Vitiligo may appear at any age. There is an increased rate of the condition in some families.

Vitiligo is associated with other autoimmune diseases:

  • Addison disease (disorder that occurs when the adrenal glands do not produce enough hormones)
  • Thyroid disease
  • Pernicious anemia (decrease in red blood cells that occurs when the intestines cannot properly absorb vitamin B12)
  • Type 1 diabetes
What are the symptoms of Vitiligo?

Flat areas of normal-feeling skin without any pigment appear suddenly or gradually. These areas have a darker border. The edges are well defined, but irregular.

Vitiligo most often affects the face, elbows and knees, back of the hands and feet, and genitals. It affects both sides of the body equally.

Vitiligo is more noticeable in darker-skinned people because of the contrast of white patches against dark skin.

No other skin changes occur.

Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Vitiligo?

Vitiligo is difficult to treat and repigmentation is slow (months to years). Early treatment options include the following:

  • Phototherapy, a medical procedure in which your skin is carefully exposed to limited amounts of ultraviolet light. Phototherapy may be given alone, or after you take a medicine that makes your skin sensitive to light. A dermatologist performs this treatment.
  • Certain lasers may help the skin repigment.
  • Ruxolitinib (Opzelurea) is a topical cream that became the first FDA-approved treatment for vitiligo in 2022.
  • Other medicines applied to the skin, such as corticosteroid creams or ointments, immunosuppressant creams or ointments such as pimecrolimus (Elidel) and tacrolimus (Protopic) can be considered.

Skin may be moved (grafted) from normally pigmented areas and placed onto areas where there is pigment loss.

Several cover-up makeups or skin dyes can mask vitiligo. Ask your provider for the names of these products.

In extreme cases when most of the body is affected, the remaining skin that still has pigment may be depigmented, or bleached. This is a permanent change that is used as a last option.

It is important to remember that skin without pigment is at greater risk for sun damage. Be sure to apply a broad-spectrum (UVA and UVB), high-SPF sunscreen or sunblock. Sunscreen can also be helpful for making the condition less noticeable, because unaffected skin may not darken in the sun. Use other safeguards against sun exposure, such as wearing a hat with a broad rim and long sleeve shirt and pants.

Who are the top Vitiligo Local Doctors?
Elite in Vitiligo
Dermatology
Elite in Vitiligo
Dermatology
Referral required

Sunnyvale Center (401)

401 Old San Francisco Road, Level 2, 
Sunnyvale, CA 
Languages Spoken:
English
Accepting New Patients

Amit Pandya is a Dermatologist practicing medicine in Sunnyvale, California. Dr. Pandya is rated as an Elite provider by MediFind in the treatment of Vitiligo. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Porphyria Cutanea Tarda, Melasma, and Thrombectomy. Dr. Pandya is board certified in Dermatology. Dr. Pandya is currently accepting new patients.

Elite in Vitiligo
Elite in Vitiligo
Referral may be required

UPMC Shadyside Dermatology

580 South Aiken Avenue, Suites 200 & 201, 
Pittsburgh, PA 
Languages Spoken:
English, Hindi
Accepting New Patients
Offers Telehealth

Anuradha Bishnoi is a Dermatologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Bishnoi is rated as an Elite provider by MediFind in the treatment of Vitiligo. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Lichen Planus, and Melasma. Dr. Bishnoi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Vitiligo
Family Medicine
Elite in Vitiligo
Family Medicine

Office

7500 Dollarway Rd Ste 104, 
White Hall, AR 
Languages Spoken:
English
Accepting New Patients

John Harris is a primary care provider, practicing in Family Medicine in White Hall, Arkansas. Dr. Harris is rated as an Elite provider by MediFind in the treatment of Vitiligo. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Hypomelanotic Disorder, Vitiligo, Obesity in Children, and End-Stage Renal Disease (ESRD). Dr. Harris is currently accepting new patients.

What are the support groups for Vitiligo?

More information and support for people with vitiligo condition and their families can be found at:

  • Vitiligo Support International - vitiligosupport.org
What is the outlook (prognosis) for Vitiligo?

The course of vitiligo varies and is unpredictable. Some areas may regain normal pigment (coloring), but other new areas of pigment loss may appear. Skin that is repigmented may be slightly lighter or darker than the surrounding skin. Pigment loss may get worse over time.

When should I contact a medical professional for Vitiligo?

Contact your provider for an appointment if areas of your skin lose their coloring for no reason (for example, there was no injury to the skin).

What are the latest Vitiligo Clinical Trials?
A Phase 2, Randomized, 24-Week, Multicenter, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Non-Segmental Vitiligo

Summary: The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study wi...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy and Safety of Ruxolitinib Phosphate Cream Combined With Corticosteroids in Patients With Progressive Non-Segmental Vitiligo: A Multicenter Real-World Study

Summary: This study is a prospective, multicenter, real-world observational study to assess the clinical efficacy and safety of topical 1.5% Ruxolitinib phosphate cream used in combination with systemic corticosteroids in a real-world clinical setting. The study plans to observe patients aged 12 years and older with active, progressive non-segmental vitiligo involving the face. All treatments are prescribe...

Who are the sources who wrote this article ?

Published Date: April 09, 2026
Published By: Elika Hoss, MD, Assistant Professor of Dermatology, Mayo Clinic, Scottsdale, AZ. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Dinulos JGH. Light-related diseases and disorders of pigmentation. In: Dinulos JGH, ed. Habif's Clinical Dermatology. 7th ed. Philadelphia, PA: Elsevier; 2021:chap 19.

James WD. Disorders of pigmentation. In: James WD, ed. Andrews' Diseases of the Skin. 14th ed. Philadelphia, PA: Elsevier; 2026:chap 31.

Seneschal J, Passeron T, Torrelo A, Ortonne J-P. Vitiligo and other disorders of hypopigmentation. In: Bolognia JL, Schaffer JV, Cerroni L, eds. Dermatology. 5th ed. Philadelphia, PA: Elsevier; 2025:chap 66.